Quality Assurance / QA Quality Control / QC Production

f.c.tablets(450+50)mg/tabBt x 30 δισκία




DIOSPER acts as additional treatment to the implications of chronic venous impairment of the nether limbs.

DIOSPER is contraindicated in case of hypersensitivity to any of the formulation's ingredients.




The recommended dose for DIOSPER is 2 tablets daily, 1 tablet in the morning and 1 tablet in the evening, always during meals.

There is no need of dose adjustment on special populations.

It should not be given to children.


Method of administration


Route of administration: oral and only after physician's prescription.

Tablets must be swallowed unchewed with a glass of water during meals.


« previous page
Latest News Sale Points of Kleva Worldwide
"Rumors have no full name"

 (Available only in Greek version)

smallmap loading...
Read More Read More
© Kleva 2009 All rights reserved. Home Page| Introduction | Message from the President | Latest news - Announcements | Publications - Articles - Interviews | Quality Assurance / QA | Research and Development Directorate (R&D) | Directorate of Production | Our History | Inspection Programmes | Member's Registration Form | Newsletter | Directorate of Business Development (BD) | Our Strategy | Quality Control / QC | Sponsorships | Directorate of Regulatory Affairs (RA) | Contact | Directorate of Pharmacovigilance | Our Facilities | | Contact